# Synjardy

NDC: 0597-0168
Generic name: empagliflozin and metformin hydrochloride
Labeler / Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20150826

FDA application: NDA206111

## Active ingredients

- EMPAGLIFLOZIN: 12.5 mg/1
- METFORMIN HYDROCHLORIDE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0597-0168"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0597-0168
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fdd0255-0055-65f3-b2c0-db8fbb87beae